CELLECTAR BIOSCIENCES INC (CLRB) Forecast, Price Target & Analyst Ratings

NASDAQ:CLRB • US15117F8804

Current stock price

3.04 USD
+0.09 (+3.05%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CELLECTAR BIOSCIENCES INC (CLRB).

Forecast Snapshot

Consensus Price Target

Price Target
$35.36
+ 1,063.16% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$1.71
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$35.36
Upside
+ 1,063.16%
From current price of $3.04 to mean target of $35.36, Based on 9 analyst forecasts
Low
$10.10
Median
$18.36
High
$79.80

Price Target Revisions

1 Month
-26.24%
3 Months
-26.24%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for CLRB. The average price target is 35.36 USD. This implies a price increase of 1063.16% is expected in the next year compared to the current price of 3.04.
The average price target has been revised downward by 26.24% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CLRB Current Analyst RatingCLRB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

CLRB Historical Analyst RatingsCLRB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
CLRB was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CLRB.
In the previous month the buy percentage consensus was at a similar level.
CLRB was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-10Maxim GroupUpgrade Hold -> Buy
2025-05-14Maxim GroupDowngrade Buy -> Hold
2024-12-11OppenheimerDowngrade Outperform -> Perform
2024-11-19OppenheimerMaintains Outperform -> Outperform
2024-10-11OppenheimerReiterate Outperform -> Outperform
2024-03-28Roth MKMMaintains Buy -> Buy
2024-03-28OppenheimerReiterate Outperform -> Outperform
2024-03-04Roth MKMReiterate Buy -> Buy
2022-11-04HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$1.71
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
59.20%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
29.11%
EPS (3 Months)
16.97%

Next Earnings Summary

CLRB is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -1.71 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CLRB revenue by date.CLRB revenue by date.
N/AN/AN/A
221.63%		N/A
32.42%		N/A
35.86%		N/A
-27.64%		N/A
159.09%		N/A
60.65%
EBITDA
YoY % growth
CLRB ebitda by date.CLRB ebitda by date.
-8.2M-9.09M
-10.85%		-12.05M
-32.56%		-11.57M
3.98%		-14.05M
-21.43%		-15.16M
-7.90%		-23.98M
-58.18%		-28.66M
-19.52%		-38.768M
-35.27%		-51.486M
-32.80%		-22.766M
55.78%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CLRB ebit by date.CLRB ebit by date.
-8.56M-9.45M
-10.40%		-13.6M
-43.92%		-11.65M
14.34%		-14.18M
-21.72%		-15.3M
-7.90%		-24.13M
-57.71%		-28.81M
-19.39%		-38.961M
-35.23%		-51.778M
-32.90%		-22.98M
55.62%		N/A
-16.79%		N/A
-6.33%		N/A
58.46%		N/A
78.12%		N/A
563.21%		N/A
100.58%		N/A
159.72%		N/A
106.43%
Operating Margin
CLRB operating margin by date.CLRB operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CLRB eps by date.CLRB eps by date.
N/AN/A-3,210.00
-94.26%		-1,818.00
43.36%		-591.00
67.49%		-270.00
54.31%		-129.00
52.22%		-121.50
5.81%		-87.90
27.65%		-36.90
58.02%		-10.29
72.11%		N/A
63.59%		N/A
16.24%		N/A
70.31%		N/A
167.52%		N/A
384.30%		N/A
113.11%		N/A
-56.95%		N/A
99.64%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.71
59.20%		-0.71
79.09%		-0.68
51.53%		-0.52
60.07%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-6.482M
-1.27%		-6.729M
-11.46%		-7.149M
-47.37%		-7.401M
-30.05%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CLRB Yearly Revenue VS EstimatesCLRB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M 250M
CLRB Yearly EPS VS EstimatesCLRB Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -1K -2K -3K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.06%
EPS Next 5 Year
18.09%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CELLECTAR BIOSCIENCES INC / CLRB Forecast FAQ

What do analysts expect the price target to be for CELLECTAR BIOSCIENCES INC (CLRB)?

9 analysts have analysed CLRB and the average price target is 35.36 USD. This implies a price increase of 1063.16% is expected in the next year compared to the current price of 3.04.

When does CELLECTAR BIOSCIENCES INC (CLRB) report earnings?

CELLECTAR BIOSCIENCES INC (CLRB) will report earnings on 2026-05-11.

What are the consensus estimates for CLRB stock next earnings?

The consensus EPS estimate for the next earnings of CELLECTAR BIOSCIENCES INC (CLRB) is -1.71 USD and the consensus revenue estimate is 0 USD.

How do analysts rate CELLECTAR BIOSCIENCES INC (CLRB)?

The consensus rating for CELLECTAR BIOSCIENCES INC (CLRB) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.